FDA Revises Letter of Authorization for the Emergency Use Authorization for Paxlovid

January 29, 2024 -- In December 2021, FDA authorized Paxlovid for emergency use for the treatment of adults and pediatric patients (12 years of age and older weighing at least 40 kg) who are at high risk for progression to severe COVID-19,...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials